Department of Sports Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Am J Sports Med. 2018 Mar;46(3):663-670. doi: 10.1177/0363546517744171. Epub 2017 Dec 21.
Corticosteroid injection is a common treatment for frozen shoulder, but controversy still exists regarding the injection site with the best outcome.
To treat the frozen shoulder in the freezing stage with corticosteroid injection, a single injection into the rotator interval (RI) could yield better effects in terms of improvement in pain, passive range of motion (ROM), and function than would an injection into the intra-articular (IA) or subacromial (SA) space.
Randomized controlled trial; Level of evidence, 1.
Patients with primary frozen shoulder in the freezing stage were randomized into 3 groups: RI injection, IA injection, or SA injection with corticosteroid. Clinical outcomes were documented at baseline and at 4, 8, and 12 weeks after intervention, including visual analog scale (VAS) for pain; passive ROM measurements, including external rotation, internal rotation, forward flexion, and abduction; and evaluation with the Disability of Arm, Hand, and Shoulder (DASH) score and Constant score.
There were no significant differences in the basic properties of the 3 groups (27 in RI group, 24 in IA group, and 26 in SA group) before injection. Improvements in pain VAS, passive ROM, Constant score, and DASH score were faster and significant in the RI group from 4 weeks after injection, followed by those in the IA group. Passive ROM decreased and DASH score did not change significantly in the SA group, although pain VAS and Constant score improved significantly.
To treat frozen shoulder in the freezing stage with corticosteroid injection, a single injection into the RI yielded better effects in terms of improvement in pain, passive ROM, and function than did injections into the IA or SA space.
皮质类固醇注射是治疗冻结肩的常用方法,但注射部位与最佳疗效仍存在争议。
对于冻结期的冻结肩,皮质类固醇单次注射至旋转间隔(RI)比关节内(IA)或肩峰下(SA)注射在改善疼痛、被动活动范围(ROM)和功能方面效果更好。
随机对照试验;证据水平,1 级。
将原发性冻结肩冻结期患者随机分为 3 组:RI 注射组、IA 注射组或 SA 注射组。干预后 4、8 和 12 周记录临床结果,包括疼痛的视觉模拟量表(VAS);被动 ROM 测量,包括外旋、内旋、前屈和外展;以及使用手臂、手部和肩部残疾(DASH)评分和常数评分进行评估。
注射前 3 组(RI 组 27 例、IA 组 24 例和 SA 组 26 例)的基本特征无显著差异。从注射后 4 周开始,RI 组的疼痛 VAS、被动 ROM、常数评分和 DASH 评分改善更快且更显著,其次是 IA 组。SA 组的被动 ROM 下降和 DASH 评分无明显变化,尽管疼痛 VAS 和常数评分显著改善。
对于冻结期的冻结肩,皮质类固醇注射至 RI 可在改善疼痛、被动 ROM 和功能方面优于 IA 或 SA 注射。